BRD5648

CAS No. 2056261-42-6

BRD5648( (R)-BRD0705 )

Catalog No. M26074 CAS No. 2056261-42-6

BRD5648 is an inactive (R)-enantiomer of BRD0705.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 87 In Stock
5MG 83 In Stock
10MG 122 In Stock
25MG 204 In Stock
50MG 277 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BRD5648
  • Note
    Research use only, not for human use.
  • Brief Description
    BRD5648 is an inactive (R)-enantiomer of BRD0705.
  • Description
    BRD5648 is an inactive (R)-enantiomer of BRD0705. BRD0705 is a GSK3α inhibitor (IC50: 66 nM; Kd: 4.8 μM) and can be used in acute myeloid leukemia (AML) studies.(In Vitro):BRD5648 does not induce changes in enzyme phosphorylation or total β-catenin protein stabilization.
  • In Vitro
    BRD5648, the inactive enantiomer of BRD0705, does not induce changes in enzyme phosphorylation or total β-catenin protein stabilization.
  • In Vivo
    ——
  • Synonyms
    (R)-BRD0705
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    GSK-3
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2056261-42-6
  • Formula Weight
    321.424
  • Molecular Formula
    C20H23N3O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 300 mg/mL (933.36 mM)
  • SMILES
    CC[C@]1(C2=CNNC2=NC2=C1C(=O)CC(C)(C)C2)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • CCG 203769

    CCG 203769 is a selective inhibitor of RGS4 with an IC50 of 17 nM for the RGS4-Gαo protein-protein interaction.

  • BRD1172

    BRD1172 is a highly selective, potent, reversible, ATP-competitive GSK3 inhibitor with IC50 of 3 nM/10 nM for GSK3α/GSK3β, respectively.

  • GSK3-IN-4

    GSK3-IN-4 is a GSK-3 inhibitor with IC50 of 0.101-1 μM of GSK-3α and GSK-3β in Calipe Assay.